专题：Dementia and Cognitive Impairment Research

This cluster of papers focuses on the diagnosis, management, and impact of Alzheimer's disease, including its relationship with mild cognitive impairment, dementia, neuroimaging techniques, cognitive decline, biomarkers, aging, and the burden experienced by caregivers. It also explores the role of vascular risk factors and the potential benefits of cognitive training.
最新文献
Stroke management practices among caregivers in Hohoe Municipality, Volta Region, Ghana: a qualitative study

article Full Text OpenAlex

Vascular Cognitive Impairment and Dementia

article Full Text OpenAlex

Thirty-seven-year trends in the prevalence, incidence, and prognosis of dementia in a Japanese community: the Hisayama study

article Full Text OpenAlex

Using high‐resolution array tomography to validate the use of synaptic vesicle glycoprotein 2A as a biomarker for synaptic loss in Alzheimer's disease

article Full Text OpenAlex

Proteins Associated with Cognition in Amyloid-beta Positive Elders Based on Cerebrospinal Fluid Proteomics

article Full Text OpenAlex

Donepezil‐Induced Severe Anorexia and T‐Wave Inversion in Early‐Onset Alzheimer's Disease: A Case Report

article Full Text OpenAlex

Status and trends of transcranial magnetic stimulation research in Alzheimer's disease: A bibliometric and visual analysis

article Full Text OpenAlex

Risk reduction and precision prevention across the Alzheimer’s disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches

review Full Text OpenAlex

Language dysfunction and related amyloid-β in Alzheimer’s disease mediated by brain functional connectivity changes

article Full Text OpenAlex

Structural brain changes in people with dementia receiving Cognitive Stimulation Therapy: Preliminary findings

article Full Text OpenAlex

近5年高被引文献
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 4411 FWCI941.62056133

2023 Alzheimer's disease facts and figures

article Full Text OpenAlex 2809 FWCI1059.24683469

2022 Alzheimer's disease facts and figures

article Full Text OpenAlex 2293 FWCI489.45194003

Donanemab in Early Symptomatic Alzheimer Disease

article Full Text OpenAlex 2057 FWCI621.17512273

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

article Full Text OpenAlex 2045 FWCI1832.74890899

2024 Alzheimer's disease facts and figures

article Full Text OpenAlex 1684 FWCI1480.53848296

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

article Full Text OpenAlex 1549 FWCI1387.33267047

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

article Full Text OpenAlex 1188 FWCI210.72873706

Global estimates on the number of persons across the Alzheimer's disease continuum

article Full Text OpenAlex 721 FWCI156.0697063

Lecanemab: Appropriate Use Recommendations

article Full Text OpenAlex 651 FWCI399.23537997